Navigation Links
Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
Date:1/12/2009

clearances. Abbott and AMO expect the transaction to close in the first quarter of 2009.

Abbott Conference Call

Abbott will conduct a special conference call today at 8 a.m. Central time(9 a.m. Eastern time) to provide an overview of the transaction. The live Webcast will be accessible through Abbott's Investor Relations Web site at http://www.abbottinvestor.com.

About Advanced Medical Optics (AMO)

AMO is focused on providing the full range of advanced refractive technologies and support to help eye care professionals deliver optimal vision and lifestyle experiences to patients of all ages. The company has operations in 27 countries and markets products in approximately 60 countries. For more information, visit the company's Web site at http://www.amo-inc.com.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.

Additional Information

The tender offer described in this press release has not yet commenced, and this press release is neither an offer to purchase nor a solicitation of an offer to sell securities. At the time the tender offer is commenced, Abbott will file a tender offer statement with the U.S. Securities and Exchange Commission (SEC). Investors and AMO security holders are strongly advised to read the tender offer statement (including an offer to purchase, letter of trans
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Abbott Announces Earnings Guidance for 2009
2. Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
3. Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
4. Abbotts XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
5. Abbott Hosts Conference Call for Third-Quarter Earnings
6. Abbott to Present at UBS Best of Americas Investment Conference
7. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
8. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
9. Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent
10. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
11. Abbott Invests Additional $20M in Isis Subsidiary Ibis Biosciences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...,, CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Onc...lytics" or the "Company") today announced updated ...SIN(R) in patients with sarcomas metastatic to the...Connective Tissue Oncology Society Meeting held in...he poster presentation, entitled "A Phase II Study...
(Date:11/5/2009)... , TRANSPORTATION -- Gone hybrid . . . , Fue...mobiles are now posted at the www.fueleconomy.gov...veloped and maintains for the U.S. Department of E.... Nine of the top 10 vehicles on the best fuel eco...Prius (51 MPG city; 48 highway). "This list proves...
(Date:11/5/2009)...,, PARSIPPANY, N.J., Nov. 5 DSM...as made a manufacturing alliance with Galenix, Sai...ferred commercial scale manufacturing partner for ..., DSM and Galenix will collaborate on business de...delivery technologies, based on the strength of Ga...
(Date:11/5/2009)...,, Conference Call on Thursday, November 5, 200... VANCOUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGen...any") (NASDAQ: OGXI ) today reported unaudited fi...ths ended September 30, 2009 and reviewed the Comp..., The following consolidated results reflect the...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...eutics, Inc., the leader in fragment-based lead di..., announced successful completion of the first pha...euticals, a wholly-owned subsidiary of Biogen Idec...onix gains access to Zenobia,s technology and expe...-ray structure determination. Zenobia completed th...
...ncorporated, a medical device company, announces t...s B financing. Funding was triggered by the compan...evelopment of their image guided cancer therapy de...s led by OrbiMed Advisors and Fidelity Biosciences...ture Partners. , , "These funds will allow us to ...
...ies(TM), a division of Ben Venue Laboratories, Inc... 2 mg / mL in PVC flexible containers to its exist...P rated and is equivalent to Diflucan(R) by Pfizer...dicated for oropharyngeal and esophageal candidias... for the prophylaxis of candidiasis. , , (Logo: ...
Other Biology Technology:Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals 2ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG 2Bedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers 2
(Date:11/9/2009)...BER 9, 2009 A nutritionist whose research was ins...ederal Women, Infants and Children (WIC) food subs...Award for outstanding achievement in the field of ...D., MNS, , a professor in the Department of Commun...a, Los Angeles School of Public Health, will recei...
(Date:11/8/2009)...nd. - Researchers at Purdue University have discov...bers in spinal cord injuries using nano-spheres th...an accident. , The synthetic "copolymer micelles... diameter, or roughly 100 times smaller than the d...been studying how to deliver drugs for cancer trea...
(Date:11/8/2009)..., 2009) The loss of a gene through deletion of ge... significant abnormalities in learning and behavio...College of Medicine ( www.bcm.edu ) in a report th...etics . , "This research goes about 95 percent o...group of individuals to this gene," said Dr. Arthu...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Developmental delay could stem from nicotinic receptor deletion 2Regulatory Affairs Professionals Society 28RAPS 29 Honors 2009 RAPS Fellows 57051 1Regulatory Affairs Professionals Society 28RAPS 29 Honors 2009 RAPS Fellows 57051 2Regulatory Affairs Professionals Society 28RAPS 29 Honors 2009 RAPS Fellows 57051 3RAPS Honors Dexter Shorer and Novales Li for Outstanding Contributions to Healthcare Product Regulatory Profession 57049 1RAPS Honors Dexter Shorer and Novales Li for Outstanding Contributions to Healthcare Product Regulatory Profession 57049 2RAPS Honors Dexter Shorer and Novales Li for Outstanding Contributions to Healthcare Product Regulatory Profession 57049 3Dermatologists Screen More Than 1 300 People for Skin Cancer at Kentucky State Fair 57047 1Dermatologists Screen More Than 1 300 People for Skin Cancer at Kentucky State Fair 57047 2Dermatologists Screen More Than 1 300 People for Skin Cancer at Kentucky State Fair 57047 3
... University researchers will use a $4 million gran...the functions of genes in a plant - research which...th and agriculture. , In a collaborative effort sp...termine the functions of roughly 4,400 nuclear gen...owering plant whose entire 29,000 gene sequence is...
...pox in the United States during the summer of 2003... disease usually kills 10 percent of those infecte...ch from Saint Louis University Health Sciences Cen...n answer. , In this month,s issue of Virology, res... Saint Louis University Health Sciences Center and...
...selective logging stopped in the region now known ...uenon (Cercophithecus ascanius) is a primate still...rt in a new study, changed the ecological balance ...nd opening the door for multiple parasitic infecti...ecies, collecting 1,076 fecal samples from the hea...
Other Biology News:MSU researchers receive $4 million grant to uncover gene functions 2Monkeypox mystery: New research may explain why 2003 outbreak in the US wasn't deadly 2President Bush's cut to AIDS prevention in Africa would be devastating 2President Bush's cut to AIDS prevention in Africa would be devastating 3
...ro-fractionation, spotting and preparation for MS ...be accurately and continuously spotted onto target...ic preparation of target plates for MALDI-TOF-MS m...us Two-Dimensional Micro LC System and Shimadzu Bi...
...inase) signal transduction cascade is one of three...thway activation occurs in response to environment...tion of JNK itself, and is implicated in the immun...sformation, morphogenesis, and apoptosis.JIP1 (JNK...
HP GenomeWide siRNA from QIAGEN
... Panels were designed for full-length gene cloning...he desired cDNA clone. The first PCR analysis is p...ell contains plasmid DNA from 5,000 clones. Having...resis of the reaction products, the second PCR ana...
Biology Products: